高氧性肺损伤的机制以及重组人胰岛素样生长因子-1的干预作用的实验研究
|
摘要
本研究利用新生大鼠吸入高浓度氧的方法,建立支气管肺发育不良的动物模型,从组织病理学观察吸入高氧后新生大鼠不同时程肺组织结构改变,并应用TUNEL染色方法检测肺细胞凋亡、免疫组织化学染色和Western blot方法观察高氧性肺损伤大鼠不同时程肺组织中的Clara细胞分泌蛋白、肺表面活性物质相关蛋白-A以及转化生长因子-β受体1、2的表达变化,以了解高氧对肺损伤和肺发育阻滞的影响及其机制。并应用人重组胰岛素样生长因子-1和地塞米松进行干预后,再观察肺发育程度和肺内Clara细胞分泌蛋白、肺表面活性物质相关蛋白-A表达变化以及肺细胞凋亡程度,探讨重组人胰岛素样生长因子-1是否对高氧性肺损伤有保护作用。为今后进一步临床应用重组人胰岛素样生长因子-1预防和治疗支气管肺发育不良提供有力的理论和实验依据。另外,将来利用基因重组的方法制作Clara细胞分泌蛋白,用于支气管肺发育不良的防治研究提供可能性。
Introduction
The development of neonatology and the appearance of pulmonarysurfac-tant have been increasingly effective in reducing the mortality of very lowbirth weight infants at the expense of an increasing number of survivors withbronchopulmonary dysplasia (BPD) caused by lung immaturity. BPD is acommon syndrome in newborns, especially in preterm infants, when treated withhyperxia and mechanical ventilation. Unfortunately, there have been no effectivemedicines applied in clinic for the prevention and treatment of BPD limited by itsunclear pathogenesis.
Newborn infants with severe health problems are most prone to suffer fromhypoxemia, which may be treated with oxygen therapy to save their lives. Butmore and more cases indicate that prolonged inhalation of high concentration ofoxygen may cause acute or chronic pulmonary injury for not only lung is liable tobe attacked due to its characterized structure and position but also oxygen is akind of gas medicine with harmful side effect.
At present, new-type of BPD with the restricted lung development isconsidered most important in neonatal intensive care. BPD has been suggested toinfluence lung maturation by causing progressive and sustained lung inflammation,which would result in the depression of the development of alveoli, smallrespiratory tubes and small blood vessels. Therefore, the lung injury occurred
during the formation stage of respiratory system may result in retardation of lungdevelopment.Apoptosis, together with the characteristic death of endothelial and alveolarepithelial cells are reported to participate in the pathogenic process of lung injuryinduced by high concentration of oxygen. When lung injury occurs, thedenaturalization and destruction of type II alveolar epithelium will lead to thedecreased secretion of pulmonary surfactant protein (SP), disfunction ofpulmonary surfactants and finally to inhibit the maturation of pulmonary alveoli.Transforming growth factor-β (TGF-β) is one of the important growth regulatingfactors, which restrains the development of endothelial and epithelial cells andparticipates in the abnormal repair process after hyperoxia-induced lung injury.Clara cell secretory protein (CCSP), the major protein secreted by remotebronchiole Clara cells, is an inhibitor of secretary phospholipase A2, which takespart in the pathophysiological processes such as inflammation and tissuereconstruction.Insulin-like growth factor-1 (IGF-1), an important growth factor, plays acrucial regulatory role on cell multiplication, differentiation, apoptosis anddevelopment of organisms. It is reported that IGF-1 is related to thecompartmentation and maturation of alveoli. For example, IGF-1 expressiondecreases while exposed to hyperoxia at the alveoli stage of lung development.In this study, we are intent to establish BPD model induced by hyperoxiaexposure to observe pulmonary apoptosis, to investigate expression of CCSP,SP-A, TGF-βR1, TGF-βR2 and process of alveoli stage, and finally to discuss themechanism of hyperoxia-induced lung injury with or without external supplementof IGF-1 so that we can provide theoretical and experimental evidences forclinical prevention and treatment of BPD.ObjectiveExperimental neonatal rat BPD model, induced by prolonged exposure to
hyperoxia, was used to investigate the histomorphology, different gene expression,such as CCSP, SP-A, TGF-βR1, TGF-βR2 and cell apoptosis process, and todiscuss the influence and mechanism of hyperoxia on lung development andinjury. Meanwhile, rh-IGF-1 and Dexamethasone were delivered to the model tocompare their different effects to provide powerful theoretical and experimentalevidences of rh-IGF-1 for prevention and treatment of BPD.MethodsMechanism of hyperoxia-exposed lung injury120 full term neonatal Wistar rats and 40 full term neonatal BAL B/c rats,under the same condition were divided randomly into two groups: air controlgroup and hyperoxia group the second day after birth. Pups were allowed foodand water ad libitum and maintained on a 12h dark-light cycle. Pups in hyperoxiagroup were kept into a Plexiglas chamber and exposed to over 85% oxygen,which was monitored daily by an oxygen sensor, while pups in control group wasunder the same raising condition except for the exposure to room air. Chamberwas opened 1 hour everyday for change of water, food, bedding and exchange oflactation rats to avoid their decreasing care ability caused by oxygen toxicity.The number of dead pups was recorded and mortality was calculated on 4d,7d, 10d and14d after birth of both groups. In addition, lung tissues were obtainedat same time points following induction of anesthesia to perform hematoxylin-and eosin-stained (HE), immunohistochemistry, TUNEL, Western blot analysisand to measure wet to dry weight ratio (W/D) to examine pneumonedema.HE assay is used to evaluate the lung tissue histological changes andexamine radical alveolar counts (RAC);Immunohistochemistry is to observeexpression of CCSP, SP-A and TGF-βR1, TGF-βR2 at different time;Apoptoticcell number and index of lung tissue were calculated on day 7 and day 14 ofhyperoxia exposure by the method of TUNEL;And expression content ofTGF-βR1, TGF-βR2 after 14d of hyperoxia exposure were detected by Western
blot analysis, besides, semiquantitative analysis was performed using the Bcionimage Software.Influence of rh-IGF-1 to hyperoxia-exposed lung injury160 full term neonatal Wistar rats in the second day after birth were assignedrandomly into four groups: Ⅰair + normal sodium control group, Ⅱhyperoxia +normal sodium group, Ⅲ hyperoxia + Dexamethasone group, and Ⅳ hyperoxia +rh-IGF-1 group. BPD model were established as described before. Except forcontrol group, chambers of the other three groups were opened 1 hour everydayfor change of bedding and lactation rats. Extra control groups for Ⅲ、Ⅳ weredesigned only for change the lactation rats.Pups in group Ⅲ were administrated everyday from the third day ofhyperoxia with intraperitoneal injection of Dexamethasone (0.25mg/Kg) whilepups in group Ⅳ with rh-IGF-1 (1ug/Kg), pups in the other two groups weregiven the same dosage of normal sodium.Lung tissues of neonatal rats in every group were obtained after 7d and 14dof hyperoxia exposure to perform HE, immunohistochemistry, TUNEL analysis.HE is used to evaluate the lung tissue histological changes and examine radicalalveolar counts (RAC). Immunohistochemistry is used to observe expression ofCCSP, SP-A at different time. Apoptotic cell number and index of lung tissuewere calculated after 7d and 14d of hyperoxia exposure by the method of TUNEL.ResultsMechanism of hyperoxia lung injury1. Changes of general condition and mortality of rats exposed tohyperoxiaNeonatal rats in air group were active, sensitive, with abundant adipose layer,high appetite and were in a healthy development status while rats in the othergroup were lazy, clumsy, emaciated with bad appetite and hypoevolutism. Withprolonged hyperoxia exposure, the mortalities of both groups were increased.
Compared with air group, the mortality of hyperoxia group increased sharply after7 days of exposure, and there was significant difference between them (P<0.01).2. Pneumonedema after hyperoxia exposureThe wet to dry weight ratio of both groups had no difference at day 4 and day14 of exposure (P>0.05);but it showed a significantly increase at day 7 and day10 compared to the air control group (P<0.05).3. Lung morphology with hyperoxia(1) changes of lung histopathologyFrom birth until day 4, the terminal bronchioli of lung tissue in both groupsbranched into smooth-walled channels that ended in sacculi, the wall of whichcontained a lot of interstitial cells. The septae of the newborn lungs appeared andwere much thicker. And there were very little number of alveoli in this lungdevelopment stage. On day 7 and day 10, the number of alveoli was increased inthe air group compared to the hyperoxia group. By day 14, alveoli number of airgroup continued to multiplication resulting in a homogenous alveolar, and its wallwas thick with many interstitial cells. But for the rats of hyperoxia group, sacculicontinued to dominate, the number of small diameter alveoli decreased sharplyand distal air space enlarged obviously. On day 7 and 10 of hyperoxia exposure,edema was observed in enlarged alveoli with red blood cells and inflammatorycells in it.(2) Radical alveolar counts (RAC)The results of RAC demonstrated that there was no difference after 4 days ofhyperoixa (P>0.05) and on the other three days, RAC reduced significantlycompared to the control group (P<0.05).4. Expression of CCSP and SP-A of lung tissues with hyperoxiaexposureWith immunohistochemistry, it was found a focus of positive staining inClara cells of bronchiole epithelium. The percentage of Clara cells in distal and
respiratory bronchioles epithelium were decreased with hyperoixa compared tothat in air group (P<0.01). And statistically significant relationships were found inpositive intensity of Clara cells between hyperoxia and air group (P<0.01). Withprolonged hyperoxia, the positive ratio of Clara cells and the expression of CCSPreduced, and difference considered statistically significant (P<0.01 and P<0.05).The express of SP-A decreased on day 14 after exposure, and differenceconsidered statistically significant (P<0.01). And on day 7, the express of SP-A intwo groups has no difference (P>0.05).5. Cell apoptosis of lung tissues under hyperoxiaWith the assay of TUNEL, it showed that most apoptotic cells were alveoliand bronchi epithelial cells. The results revealed on day 7 and day 14 afterexposure, the apoptotic index were significantly higher than that in air group (P<0.01). Although cell apoptosis aggregated with the prolonged exposure time,there was no statistically difference between the two groups at every time point (P>0.05).6. Expression of TGF-βR1, TGF-βR2 of lung tissues under hyperoxiaThe results of immunohistochemistry told that on day 14 of exposure, theexpression intensity of TGF-βR1, TGF-βR2 were both higher than that in air group(P<0.01). And the positive staining was turned to mainly distribute in bronchi andalveoli epithelium and interstitial cells.It was observed with the assay of Western blot and analyzed that expressioncontent of TGF-βR1, TGF-βR2 after hyperoxia exposure were significantly morethan that of air group (P<0.05).Effect of rh-IGF-1 on lung injury induced by hyperoxia exposure1. RAC and morphological quantitative analysisCompared to air group, RAC of hyperoxia group reduced and Alveolar arealratio increased;and compared to hyperoxia and Dexamethasone groups, RAC ofrh-IGF-1 group increased and Alveolar areal ratio decreased obviously, and all
differences were considered statistically significant (P<0.01). There was nostatistically difference between Dexamethasone and hyperoixa group (P>0.05).2. Effect of rh-IGF-1 on the expression of CCSP、SP-A after hyperoxiaexposureIt was observed from the assay of immunohistochemistry that positivestaining of CCSP distributed mainly in distal and in respiratory bronchioles. Thepositive ratio of Clara cells and the expression of CCSP with hyperoxiasignificantly decreased when compared with air and rh-IGF-1 group respectively(P<0.01). In addition, differences were statistically significant betweenDexamethasone and hyperoxia groups (P<0.05).On day 7 of hyperoxia, there were no differences in the expression of SP-Abetween hyperoxia and other groups (P>0.05);but on day 14, The positive stainswith hyperoxia significantly decreased when compared with air and rh-IGF-1group respectively (P<0.05). Meanwhile, no statistically differences were foundbetween Dexamethasone and hyperoxia group (P>0.05).3. Effect of rh-IGF-1 on the pneumocyte apoptosis after hyperoxiaexposureWith the assay of TUNEL, it showed that most apoptotic cells were alveolarand bronchi epithelial cells. The apoptotic index were increased to a significantlygreater extent for the hyperoxia group compared to the air and rh-IGF-1grouprespectively (P<0.01).Conclusions1. Lung injury and developmental arrest of neonatal rats can be induced by85% hyperoxia exposure.2. Hyperoxia exposure can promote the pneumocyte apoptosis, inhabit theexpression of CCSP and SP-A, increase TGF-βR1, TGF-βR2 to suppress theformation of lung alveoli to aggregate lung injury of neonatal rats.3. Rh-IGF-1 can remove the block of the formation of lung alveoli,
increase the secretion of CCSP and SP-A to alleviate lung injury.Creation pointBronchopulmonary dysplasia has become a hot issue of neonatology with theincreased survival rates of premature infants. But its pathogenesis is still unclearand no medicine has been applied clinically with definite therapeutic effect. Andso far, no studies on the relationship of CCSP, hyperoxia and BPD, as well as theinfluence of rh-IGF-1 on lung injury induced by hyperoxia are reported indomestic. Therefore the results of this study provide a theoretic and experimentalevidence for clinic application of rh-IGF-1 to the prevention and treatment ofBPD. Furthermore, rh-CCSP obtained from gene recombination will greatlypromote the possibility of treatment of BPD.
Introduction
The development of neonatology and the appearance of pulmonarysurfac-tant have been increasingly effective in reducing the mortality of very lowbirth weight infants at the expense of an increasing number of survivors withbronchopulmonary dysplasia (BPD) caused by lung immaturity. BPD is acommon syndrome in newborns, especially in preterm infants, when treated withhyperxia and mechanical ventilation. Unfortunately, there have been no effectivemedicines applied in clinic for the prevention and treatment of BPD limited by itsunclear pathogenesis.
Newborn infants with severe health problems are most prone to suffer fromhypoxemia, which may be treated with oxygen therapy to save their lives. Butmore and more cases indicate that prolonged inhalation of high concentration ofoxygen may cause acute or chronic pulmonary injury for not only lung is liable tobe attacked due to its characterized structure and position but also oxygen is akind of gas medicine with harmful side effect.
At present, new-type of BPD with the restricted lung development isconsidered most important in neonatal intensive care. BPD has been suggested toinfluence lung maturation by causing progressive and sustained lung inflammation,which would result in the depression of the development of alveoli, smallrespiratory tubes and small blood vessels. Therefore, the lung injury occurred
during the formation stage of respiratory system may result in retardation of lungdevelopment.Apoptosis, together with the characteristic death of endothelial and alveolarepithelial cells are reported to participate in the pathogenic process of lung injuryinduced by high concentration of oxygen. When lung injury occurs, thedenaturalization and destruction of type II alveolar epithelium will lead to thedecreased secretion of pulmonary surfactant protein (SP), disfunction ofpulmonary surfactants and finally to inhibit the maturation of pulmonary alveoli.Transforming growth factor-β (TGF-β) is one of the important growth regulatingfactors, which restrains the development of endothelial and epithelial cells andparticipates in the abnormal repair process after hyperoxia-induced lung injury.Clara cell secretory protein (CCSP), the major protein secreted by remotebronchiole Clara cells, is an inhibitor of secretary phospholipase A2, which takespart in the pathophysiological processes such as inflammation and tissuereconstruction.Insulin-like growth factor-1 (IGF-1), an important growth factor, plays acrucial regulatory role on cell multiplication, differentiation, apoptosis anddevelopment of organisms. It is reported that IGF-1 is related to thecompartmentation and maturation of alveoli. For example, IGF-1 expressiondecreases while exposed to hyperoxia at the alveoli stage of lung development.In this study, we are intent to establish BPD model induced by hyperoxiaexposure to observe pulmonary apoptosis, to investigate expression of CCSP,SP-A, TGF-βR1, TGF-βR2 and process of alveoli stage, and finally to discuss themechanism of hyperoxia-induced lung injury with or without external supplementof IGF-1 so that we can provide theoretical and experimental evidences forclinical prevention and treatment of BPD.ObjectiveExperimental neonatal rat BPD model, induced by prolonged exposure to
hyperoxia, was used to investigate the histomorphology, different gene expression,such as CCSP, SP-A, TGF-βR1, TGF-βR2 and cell apoptosis process, and todiscuss the influence and mechanism of hyperoxia on lung development andinjury. Meanwhile, rh-IGF-1 and Dexamethasone were delivered to the model tocompare their different effects to provide powerful theoretical and experimentalevidences of rh-IGF-1 for prevention and treatment of BPD.MethodsMechanism of hyperoxia-exposed lung injury120 full term neonatal Wistar rats and 40 full term neonatal BAL B/c rats,under the same condition were divided randomly into two groups: air controlgroup and hyperoxia group the second day after birth. Pups were allowed foodand water ad libitum and maintained on a 12h dark-light cycle. Pups in hyperoxiagroup were kept into a Plexiglas chamber and exposed to over 85% oxygen,which was monitored daily by an oxygen sensor, while pups in control group wasunder the same raising condition except for the exposure to room air. Chamberwas opened 1 hour everyday for change of water, food, bedding and exchange oflactation rats to avoid their decreasing care ability caused by oxygen toxicity.The number of dead pups was recorded and mortality was calculated on 4d,7d, 10d and14d after birth of both groups. In addition, lung tissues were obtainedat same time points following induction of anesthesia to perform hematoxylin-and eosin-stained (HE), immunohistochemistry, TUNEL, Western blot analysisand to measure wet to dry weight ratio (W/D) to examine pneumonedema.HE assay is used to evaluate the lung tissue histological changes andexamine radical alveolar counts (RAC);Immunohistochemistry is to observeexpression of CCSP, SP-A and TGF-βR1, TGF-βR2 at different time;Apoptoticcell number and index of lung tissue were calculated on day 7 and day 14 ofhyperoxia exposure by the method of TUNEL;And expression content ofTGF-βR1, TGF-βR2 after 14d of hyperoxia exposure were detected by Western
blot analysis, besides, semiquantitative analysis was performed using the Bcionimage Software.Influence of rh-IGF-1 to hyperoxia-exposed lung injury160 full term neonatal Wistar rats in the second day after birth were assignedrandomly into four groups: Ⅰair + normal sodium control group, Ⅱhyperoxia +normal sodium group, Ⅲ hyperoxia + Dexamethasone group, and Ⅳ hyperoxia +rh-IGF-1 group. BPD model were established as described before. Except forcontrol group, chambers of the other three groups were opened 1 hour everydayfor change of bedding and lactation rats. Extra control groups for Ⅲ、Ⅳ weredesigned only for change the lactation rats.Pups in group Ⅲ were administrated everyday from the third day ofhyperoxia with intraperitoneal injection of Dexamethasone (0.25mg/Kg) whilepups in group Ⅳ with rh-IGF-1 (1ug/Kg), pups in the other two groups weregiven the same dosage of normal sodium.Lung tissues of neonatal rats in every group were obtained after 7d and 14dof hyperoxia exposure to perform HE, immunohistochemistry, TUNEL analysis.HE is used to evaluate the lung tissue histological changes and examine radicalalveolar counts (RAC). Immunohistochemistry is used to observe expression ofCCSP, SP-A at different time. Apoptotic cell number and index of lung tissuewere calculated after 7d and 14d of hyperoxia exposure by the method of TUNEL.ResultsMechanism of hyperoxia lung injury1. Changes of general condition and mortality of rats exposed tohyperoxiaNeonatal rats in air group were active, sensitive, with abundant adipose layer,high appetite and were in a healthy development status while rats in the othergroup were lazy, clumsy, emaciated with bad appetite and hypoevolutism. Withprolonged hyperoxia exposure, the mortalities of both groups were increased.
Compared with air group, the mortality of hyperoxia group increased sharply after7 days of exposure, and there was significant difference between them (P<0.01).2. Pneumonedema after hyperoxia exposureThe wet to dry weight ratio of both groups had no difference at day 4 and day14 of exposure (P>0.05);but it showed a significantly increase at day 7 and day10 compared to the air control group (P<0.05).3. Lung morphology with hyperoxia(1) changes of lung histopathologyFrom birth until day 4, the terminal bronchioli of lung tissue in both groupsbranched into smooth-walled channels that ended in sacculi, the wall of whichcontained a lot of interstitial cells. The septae of the newborn lungs appeared andwere much thicker. And there were very little number of alveoli in this lungdevelopment stage. On day 7 and day 10, the number of alveoli was increased inthe air group compared to the hyperoxia group. By day 14, alveoli number of airgroup continued to multiplication resulting in a homogenous alveolar, and its wallwas thick with many interstitial cells. But for the rats of hyperoxia group, sacculicontinued to dominate, the number of small diameter alveoli decreased sharplyand distal air space enlarged obviously. On day 7 and 10 of hyperoxia exposure,edema was observed in enlarged alveoli with red blood cells and inflammatorycells in it.(2) Radical alveolar counts (RAC)The results of RAC demonstrated that there was no difference after 4 days ofhyperoixa (P>0.05) and on the other three days, RAC reduced significantlycompared to the control group (P<0.05).4. Expression of CCSP and SP-A of lung tissues with hyperoxiaexposureWith immunohistochemistry, it was found a focus of positive staining inClara cells of bronchiole epithelium. The percentage of Clara cells in distal and
respiratory bronchioles epithelium were decreased with hyperoixa compared tothat in air group (P<0.01). And statistically significant relationships were found inpositive intensity of Clara cells between hyperoxia and air group (P<0.01). Withprolonged hyperoxia, the positive ratio of Clara cells and the expression of CCSPreduced, and difference considered statistically significant (P<0.01 and P<0.05).The express of SP-A decreased on day 14 after exposure, and differenceconsidered statistically significant (P<0.01). And on day 7, the express of SP-A intwo groups has no difference (P>0.05).5. Cell apoptosis of lung tissues under hyperoxiaWith the assay of TUNEL, it showed that most apoptotic cells were alveoliand bronchi epithelial cells. The results revealed on day 7 and day 14 afterexposure, the apoptotic index were significantly higher than that in air group (P<0.01). Although cell apoptosis aggregated with the prolonged exposure time,there was no statistically difference between the two groups at every time point (P>0.05).6. Expression of TGF-βR1, TGF-βR2 of lung tissues under hyperoxiaThe results of immunohistochemistry told that on day 14 of exposure, theexpression intensity of TGF-βR1, TGF-βR2 were both higher than that in air group(P<0.01). And the positive staining was turned to mainly distribute in bronchi andalveoli epithelium and interstitial cells.It was observed with the assay of Western blot and analyzed that expressioncontent of TGF-βR1, TGF-βR2 after hyperoxia exposure were significantly morethan that of air group (P<0.05).Effect of rh-IGF-1 on lung injury induced by hyperoxia exposure1. RAC and morphological quantitative analysisCompared to air group, RAC of hyperoxia group reduced and Alveolar arealratio increased;and compared to hyperoxia and Dexamethasone groups, RAC ofrh-IGF-1 group increased and Alveolar areal ratio decreased obviously, and all
differences were considered statistically significant (P<0.01). There was nostatistically difference between Dexamethasone and hyperoixa group (P>0.05).2. Effect of rh-IGF-1 on the expression of CCSP、SP-A after hyperoxiaexposureIt was observed from the assay of immunohistochemistry that positivestaining of CCSP distributed mainly in distal and in respiratory bronchioles. Thepositive ratio of Clara cells and the expression of CCSP with hyperoxiasignificantly decreased when compared with air and rh-IGF-1 group respectively(P<0.01). In addition, differences were statistically significant betweenDexamethasone and hyperoxia groups (P<0.05).On day 7 of hyperoxia, there were no differences in the expression of SP-Abetween hyperoxia and other groups (P>0.05);but on day 14, The positive stainswith hyperoxia significantly decreased when compared with air and rh-IGF-1group respectively (P<0.05). Meanwhile, no statistically differences were foundbetween Dexamethasone and hyperoxia group (P>0.05).3. Effect of rh-IGF-1 on the pneumocyte apoptosis after hyperoxiaexposureWith the assay of TUNEL, it showed that most apoptotic cells were alveolarand bronchi epithelial cells. The apoptotic index were increased to a significantlygreater extent for the hyperoxia group compared to the air and rh-IGF-1grouprespectively (P<0.01).Conclusions1. Lung injury and developmental arrest of neonatal rats can be induced by85% hyperoxia exposure.2. Hyperoxia exposure can promote the pneumocyte apoptosis, inhabit theexpression of CCSP and SP-A, increase TGF-βR1, TGF-βR2 to suppress theformation of lung alveoli to aggregate lung injury of neonatal rats.3. Rh-IGF-1 can remove the block of the formation of lung alveoli,
increase the secretion of CCSP and SP-A to alleviate lung injury.Creation pointBronchopulmonary dysplasia has become a hot issue of neonatology with theincreased survival rates of premature infants. But its pathogenesis is still unclearand no medicine has been applied clinically with definite therapeutic effect. Andso far, no studies on the relationship of CCSP, hyperoxia and BPD, as well as theinfluence of rh-IGF-1 on lung injury induced by hyperoxia are reported indomestic. Therefore the results of this study provide a theoretic and experimentalevidence for clinic application of rh-IGF-1 to the prevention and treatment ofBPD. Furthermore, rh-CCSP obtained from gene recombination will greatlypromote the possibility of treatment of BPD.
引文
1. Chinoy MR. Lung growth and development. Front Biosci, 2003,1:392-398.
2. Singh G, Katyal SL, Clara Cell Proteins.Annals of the New York Academy of Sciences, 2000,923:43-58.
3. Singh G, Katyal SL. Clara cells and Clara cell 10 kD protein (CC10). Am J Respir Cell Mot Biol 1997,17:141-143.
4. Chowd hury B, Mantile-Selvaegi G, Kundu GC, et al. Amino acid residues in alpha-helix-3 of human uteroglobin are critical for its phospholipase A2 inhibitory activity. Ann N Y Acad Sci 2000,923:307-311.
5. Thomas NS, Holgate ST. Genes for asthma on chromosome 11: Clin Exp Allergy 1998,28.
6. Arsalane K, Broeckaert F, Knoops B, et al. Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopoly saccharide admini stration. Am J Respir Crit Care Med, 2000,161:1624-1630.
7. Jensen SM, Jones JE, Pass H, Steinberg SM, Linnoila RI. Clara cell 10 kDa protein mRNA in normal and atypical regions of human respiratory epithelium. Int J Cancer, 1994,58:629-637.
8. Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med, 1999,159:646-678.
9. Bochskanl R, Thie M, Kirchner C. Progesterone dependent uptake of uteroglobin by rabbit endometrium. Histochemistry, 1984,80:58.
10. Umland TC, Swaminathan S, Singh, warty v, Furey W, rlecher j, et ai Structure of a human Clara cell phospholipid-binding protein-ligand complexat 1.9 A resolution. Nat Struct Biol, 1994,1:538-45.
11. Murakami M, Kudo 1 Phospholipase A2. J Biochem (Tokyo), 2002,131:285.
12. Geerts L, Jorens PG, Willems J, et al. Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med, 2001,29(10)1920-1924.
13. Lesur O, Bernard A, Arsalane K, et al. Clara cell protein (CC16) induces a phospholipase A2-mediated inhibition of fibrobla-stmigration in vitro [J]. Am J Respir Crit Care Med, 1995,152:290.
14. Geerts L, Jorens PG, Willems J, et al. Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med, 2001:29(10):1920-1924.
15. Rossini GP, Fayard JM, Tessier C, Laugier C. Binding and internization of extracellular type-I phospholipase A2 in uterine stromal cells. Biochem J 1996,315(Pt3):1007-1014.
16. Zhang Z, Kundu GC, Yuan CJ, Ward JM, Lee EJ, DeMayo F, et al. Severefibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science, 1997,276:1408-1412.
17. SpeerC P. New insights in to the pathogenesis of pulmonary inflammation in pre term infants. Biology of the Neonate, 2001,79(3-4):205-209.
18. Lundstrom KE, S haw NJ, T homsonM A.C hronicl ungd isease-cracking the cond ition in the 2 1st century. Biology of the Neonate, 2000,78(2):233-268.
19. Eber E, Zach MS. long term seguelase of bronchopulmonary dysplasia (chronic lung disease of fancy). Thorax, 2001,56:317-323.
20. Lee WL, Downey GP. Neutrophil activation and acute lung injury Currency Opinion in Critical, 2001,7:1-7.
21. 巢建新, 庄得义, 等. 支气管肺发育不良的研究进展. 国外医学儿科学分册. 2005,32(7):207-210.
22. Baier RJ, Loggins J, Kruger TE. Increased interleukin-8 and monocyte chemoattractant protein-1 concentrations in mechanicaly ventilated preter infants with pulmonary hemorrhage. Pediatr Pulmonol, 2002,34(2):131-137.
23. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res, 1999,6(6):641-664.
24. Vyas JR, Kotecha S. The effects of antenatal and postnatal corticosteroids on the preterm lung. Arch DisChild Fetal Neonatal, 1997,77:F147-150.
25. 张向锋, Hussein D.Foda. 高氧所致急性肺损伤大鼠肺组织细胞凋亡的影响. 中华结核和呼吸杂志, 2004,27(7):465-467.
26. 袁莉 . 高氧性肺损伤的研究进展 . 国外医学麻醉学与复苏分册 , 2003,23(3):1001-1005.
27. Gavino R, Johnson L, Bhandari V, et al. Release of cytokines and apoptosis in fetal rat type 2 pneumocytes exposed to hyperoxia and nitric oxide: modulatory efect of dexamethasone and pentoxi line. Cytokine, 2002,21:247-255.
28. Mantel LL, Lee PJ. Singnal transduction pathways in hyperoxia-induced lung cel death. OL Genet Metab, 2000,71:359-370.
29. Cain K, Bratton SB, Langlais C, et al. Apdf -1 oligomerizes into biologically Active approximately 700-kDa and inactive approximately 1, 4-MDa apoptocomplexes. J Biol Chem, 2000,275:6067-6070.
30. Auten RL, Ekekezie II. Blocking leukocyte influx and function to prevent chronic lung disease of prematurity. Pediatr Pulmonol, 2003,35:335-341.
31. 朱晓东, 林庚金. 凋亡通路及其调控研究进展. 国外医学生理.病理科学 及临床分册, 2002,22:248-250.
32. Nanxin L. Is NF-kB the sensor of oxidative stress? Faseb Journal, 1999,13:1137-1143.
33. Li Y, Zhang W, Mantel LL, et a1. Nuclear factor-kappaB is activated by hypemxia but does not protect from cell death. J Biol Chem, 1997,272:20646-20649.
34. Jan ssen YM, Van Houten B, Born PJ, et a1. Cel and tissue responses to oxidative damage. Lab Invest, 1993,69:261-274.
35. Reynolds SD, Mango GW, Gelein R, et al. Normal function and lack of fibronectin accumulation in kidneys of Clara cell secretory protein auteroglobin deficient mice. Am J Kidney Dis, 1999,33:541-551.
36. Broeckaert F, Bernard A. Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy, 2000,30(4):469-475.
37. Hermans C, Knoops B, Wiedig M, et al. Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J, 1999,13(5):1014-1021.
38. Ramsay PL ,DeMayo FJ, Hegemier SE, et al. Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001, 164: (1)155-161.
39. Pilon AL. Rationale for the development of recombinant human CC10 as a therapeutic for inflammatory and fibrotic disease. Ann N Y Acad Sci, 2000,923:280-299.
40. Chandra S, Davis JM, Drexler S, et al. Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury. Pediatr Res, 2003,54:509-515.
41. 王颖. 支气管肺发育不良 (新生儿慢性肺疾病) 的诊断与治疗. 实用医学杂志, 2005,21(17):1859-1860.
42. Saugstad OD. Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD? Acta Paediatr, 1997,86(12):1277-1282
43. Korhonen P, Tammela O, Koivisto AM, et al. Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants. Early Hum Dev, 1999,54(3):245-258.
44. Veness KA, Bottone FG Jr, Stiles AD. Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed new born rats. Pediatr Res, 2000,48(4):434-444.
45. Gaddipati JP, Mani H, Banaudha KK, et al. Picroliv modulates the expression of insulin-like growth factor (IGF)-I, IGF-II and IGF-I receptor during hypoxia in rats. Cell Mot Life Sci, 1999,56(3-4):348-355.
46. Stick S. Pediatric origins of adult lung disease. In the contribution of airway development to paceiatric and adult lung desease. Thorax, 2000,55(7):587-594.
47. Morrow SA, Stahl J. Apoptosis in neonatal murine lung exposed to hyperoxia. Am J Respir Cell Mol Biol, 2001,25(2):150-155.
48. Veness KA, Bottone FG, Stiles AD. Effects of fetinoic acid on airspace development and lung collagen in hyperoxia-exposed newbom rats. Pediatr Res, 2000,48(4):434-444.
49. 钱莉玲, 常立文, 容志惠, 等. 维甲酸治疗新生大鼠高氧肺发育受抑对肺组织基质蛋白酶及其组织抑制剂表达的影响. 实用儿科临床杂志, 2002,17(6):602-604.
50. Cherif A, Marrakchi Z, Chaouachi S, et al. Broncho pulmonary dysplasia and corticosteroid therapy. Arch Pediatr, 2002,9:159-168.
51. 万秋红. TGF-β超家族信号传递机制研究进展. 国外医学分子生物学分册, 2000,22(3):137-142.
52. Buckley S, Barsky L, Driscoll B, et al. Apoptosis and DNA damage in type 2 alveolar epithelial cells cultured from hyperoxic rats. Am J Physiol, 1998,274(5Pt1):L714-L720.
53. 袁安波, 石晓峰, 上官明, 等. 新生儿急性肾功能衰竭时血、尿胰岛素样生长因子-I 的变化及意义. 中华儿科杂志, 2003,21(5):306-308.
54. 贲晓明. 胰岛素样生长因子与机体营养代谢和免疫功能. 国外医学儿科学分册. 2000,27:57-59.
55. 白波, 陈波. IGF s 在 IUGR 儿生后追赶生长中的作用. 国外医学妇幼保健分册, 1999,10:112-124.
56. 白波. 胰岛素样生长因子与胎儿生长发育. 国外医学儿科学分册. 2000,27:4-6.
57. 陈 娟 . 胰 岛 素 样 生 长 因 子 与 生 长 发 育 . 中 华 围 产 医 学 杂 志 . 1999,2:126-128.
58. Bimbacher R, Amann G,Breitschopf H, et al. Cellular localization of insulin-like growth factor II mRNA in the human fetus and the placenta: detection with a digoxigenin-labeled cRNA probe and immunocytochemistry. Pediatr Res, 1998,43(5):614-620.
59. Moreno B, Rodriguez-Manzaneque JC, Perez-Castillo A, et al. Thyroid hormone controls the expression of insulin--like growth factor I recptor gene at different levels in lung and heart of developing and adult rats. Endocrinology, 1997,138: 1194-1203.
60. Lee CI, Goldstein O, Han VK, et al. IGF-II and IGF binding protein (IGFBP-1, IGFBP-3) gene expression in fetal rhesus monkey tissues during the second and third trimesters. Pediatr Res,. 2001,49(3):379-87.
61. Vande Wetering JK, Elfring RH, Oosterlaken MA, et al. Perinatal expression of IGFBPs in rat lung and its hormonal regulation in fetal lung explants. Am J Physiol, 1997,273(6Pt1):L1174-1178.
62. Kumar VH, Ryan RM.Growth factors in the fetal and neonatal lung. Front Biosci, 2004,1(9):464-80.
63. Tarantal AF, Hunter MK, Gargosky SE. Direct distribution of insulin-like growth binding protein mRNAs and peptides during rat lung deveopment. Endocrinology, 1997,155:313.
64. Wallen LD, Han VK. Spactial and temporal distribution of insulin-like grow th factors I and II during development of rat lung, Am J Physiol, 1994,267:L531-542.
65. Besnard V, Corroyer S, Trugnan G, et al. Distinct paterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells. Biochim Biophys Acta, 2001,1538(1):47-58.Griffin M,
66. 刘汉楚, 常立文, 容志惠, 等. 胰岛素样生长因子与新生大鼠高氧性肺损伤的关系. 中华儿科杂志, 2004,7:532-533.
67. Bhandari R, Hamilton G, et al. Alveolar type II cell fibroblast interactions, synthesis and secretion of surfactant and type I collagen. J Cell Sci, 1993,105(pt2):423-432.
68. Noguchi A, Nelson T. IGF-I stimulates tropoclastin synthesis in neonatal rat pulmonary fibroblasts. Pediatr Res, 1991,30:248-251.
69. Chadelat K, Boule M, Corroyer S, et al. Expression of insulin-like growth factors and their binding proteins by bronchoalveolar cells from children with and without interstitial lung disease. Eur Respir J, 1998,11(6):1329-1336.
70. Cazals V, M uhieddinc B, Maitre B, et al. Insulin-like growth factor, their binding proteins, and transforming growth factor bctal in oxidant-arrested lung alveolar epithelial cells J Biol Chem, 1994,269:14111-14117.
71. 龚小慧, 孙波. 急性肺损伤时肺表面活性物质的变化及意义. 国外医学儿科学分册. 2005,32(1):34-36.
72. Krein PM, Sabatini PJ, Tinmouth W, et al. Localization of insulin-like growth factor-I in lung tissues of patients with fibroproliferative acute respiratory distress syndrome. Am J Respir Crit Care Med. 2003,167(1):83-90.
73. Chaillry HB, Rubio S, Rougier JP, et al. Expression hydrophilic surfactant protein by mesentery cell in rat and man. Biochem J, 1997,328(Pt1):251-256.
74. 陶少华. 人肺表面活性物质结合蛋白 A 的研究现状. 国外医学妇幼保健分册, 1997,8:117.
75. Levine AM, Whitsett JA.Pulmonary collectins and innate dedense of the lung. Microbers infect, 2001,3(2):161-166.
76. Hickman-Davis JM, Fang FC, Nathan C, et al. Lung surfactant and reactive oxygen nitrogen species: antimicrobial activity and host pathogen interactions. Am J Physiol Lung Cell Mol Physiol, 2001,281(3):L517-523.
77. Mccormack FX, Whitsett JA. The pulmonary collection SP-A and SP-D, orchestrate innate immunity in the lung. J Clin logest, 2002,109(6):707-712.
78. Wu YZ, Medjane S, Chabot S, et al. Surfatant protein-A and phosphatidylglycerol suppress type Ⅱ A phospholipase A2 synthesis vianuclear factor kappab. Am J Respir Crit Care Med, 2003,168(6):692-699.
79. Quintero OA, KorThagen TR, Wright JR.Surfactant protein A regulates surfactant phospholipid clessnce after LPS-induced injury in vivo. Am J Physiol Lung Cell Mol Phydiol, 2002,283(1):76-85.
80. Schyjze O, Wesse J. Oxygen radical sassecond messen ger sofgen of gene expression. Dtsch Med Wochenschr, 1996,121:1301-1302.
81. Jobe AH, Ikegami M. Surfactant and acute 1ung injury. Proc Assoc Am Physicians, 1998,110(6):489-495.
82. Hasting RH, Monitoring alveolar epithelial function in acute lung injury. J Clin Monit Comput, 2000,16(5)385-392.
83. Cheng IW, Ware LB, Greene KE, et al. Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med, 2003,31(1):20-27.
84. Bersten AD, Hunt T, Nicholas TE, et al. Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute resp iratory failure. Am J Respir Crit Care Med, 2001,164:648
85. Attalah HL, Wu Y, Alaoui AM, et al. Induction of type-ⅡA secretory phospholipase A2 in animal models of acute lung injury. Eur Respir J, 2003,21(6):1040-1045.
86. Chabot S, Koumanov K, Lambeau G, et al. Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2. J Immunol, 2003,171(2):995-1000.
87. Mallampalli RK, Ryan AJ, Salome RG, et al. Tumor necrosis factor-alpha inhibits expression of CTP: phosphocholine cytidylyltransferase. J Biol Chem, 2000,275(13):9699-9708.
88. Creuwels LAJM, van Golde LMG, Haagsman HP. The pulmonary surfactant system. biochemical and clinical aspects Lung, 1997,175:1-39.
89. Holm BA, Enhorning G, Notter RH.Abiophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids, 2002,49:49-55.
90. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol, 2003,8(1):73-81.
91. Vancher YE. Bronchopulmonary dysplasia: an enduring chalenge. Pediatr Rev, 2002,23(3):349-358.
92. Greene KE, Wright JR, Steinberg KP, et al. Serial changes in surfactant associated proteins in lung serum beform and after onsed of ARDS. Am J Respir Crit Care Med, 1999,160(6):1843-1850.
93. Moya FD, Montes HF, ThomasuL, et al. Surfactant protein-A and saturated phatidyl cholinein respiratory distress syndrome. Am J Respir Crit Care Med, 1999,150:1672-1677.
94. Crdoso WV, Mitsialis SA, Brody JS, et al. Retinoic acid alters the expression of pattern-related genes in the developing rat lung. Dev Dyn, 1996,207(1):47-59.
95. Fu ZW, NoguchiT, Kato H. Vitamin A deficiency reduces insulin-like growth factor (IGF)-I gene expression and increases IGF-I receptor and insulin receptor gene expression in tissues of Japanese quail .J Nutr, 2001,131(4):1189-1194.
96. sbeyrat E, Besnard V, Corroyer S, et al. Retinoic acid-induced proliferation of lung alveolar epithelial cells: relation with the IGF system, Am J Physiol, 1998,275(1pt1):L71-79.
97. Halliday HL. The effect of postnatal steroids on growth and development. J Perinat Med, 2001,29(4):281-285.
98. Massaro GD, Massaro D. Postnatal treatment with retinoic acid incrases the number of pulmonary alveoli in rats. Am J Physiol. 1996,270(2Ptl):L305-310.
99. Vande JK, Elfring RH, Oosterlaken MA, et al. Perinatal expression of IGFBPs in rat lung and its hormonal regulation in fetal lung explants. Am J Physiol, 1997,273(6 Pt1):L1174.
100.Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol, 2000,279(3):L600-607.
101.Lensmar C, Nord M, Gudmundsson GH, et al. Decreased pulmonary levels of the anti-inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics. Cell Mol Life Sci, 2000,57:976-981.
102.迟春花, 何冰, 汤秀英, 等. 烟草雾吸入导致慢阻肺机制的实验研究-大鼠 Clara 细 胞 结 构 及 其 分 泌 蛋 白 的 变 化 . 心 肺 血 管 病 杂 志 , 2000,19(3):224-227.
103.汪隽瑛, 等. 哮喘大鼠肺表面活性物质结合蛋白 A 的变化及其意义. 第二军医大学学报, 2004,25(11):1255-1257.
104.Hayashi T, Stekler-Stevenson WG, Fleming MV, et al. Immunohistochemical study of metalloprpteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol, 1996,149(4):1241-1256.
105.Muler W, Pichler G. Results of mechanical ventilation in premature infants with respiratory distress syndrome. Wien Med Wochenschr, 2002,152(12):5-8.
106.Jobe AH. Lung development and lung injury-the new BPD. 中国当代儿科杂志, 2001,3(4):433-437.
107.富建华, 薛辛东. 转化生长因子-β与早产儿慢性肺疾病. 中华儿科杂志, 2003,41:313-315.
108.Jobe AH. Lung development and maturation. In: Fanarof AA, Martin RJ. eds. Neonatal-Prenatal Medicine: Diseases of the fetus and infant. Philadelphia. Elsevier Science, 2002,973.
109.Speer CP. Newin sights in to the pathogenesis of pulmonary inflammation in preterm infants. Biology of the Neonate, 2001,79(3-4):205-209.
110.VyasJR, KotechaS. The effects of an tenatal and postnatal corticosteroids on the preterm lung. Arch Dischild Fetal Neonatal, 1997,77:F147-150.
111.Editorial. preand postnatal lung development, maturation, and plasticity. Am J Physiol Lung Cell Mol Physiol, 2002,282:L341-L344.
112.Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res, 1999,6(6):641-643.
113.Bilodeau JF, Faure R, Piedboeuf B, et al. Hyperoxia induces S-phase cell-cycle arrest and p21 (Cipl/Wafl)-independent Cdk2 inhibition in humacarcinoma T47D-H3 cells. Exp Cell Res, 2000,256(2):347-357.
114.富建华, 薛辛东. 细胞因子在早产儿慢性肺疾病发生中作用, 中国当代儿科杂志, 2003,5:488-490.
115.Qin LL, Chang LW, Zhang QS, et al. Lung injury of preterm rats induced by prolonged exposour to high oxygen concentration of 85%. Chin J Contemp Pediatr, 2003,(2)95-99.
116.Moss TJ, Newnham JP, Wilett KE, et al. Early gestational intra-amniotic endotoxin. lung function, surfactant, and morphometry. Am J Respir Crit Care Med, 2002, 15:165(6):805-811.
117.Jobe AH, Ikegami M. Prevention of bronchopulmonary dysplasia. CurrOpin Pediatr, 2001,3(2):124-129
118.Coalson JJ, Winter VT, Siler-Khodr T, et al. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med, 1999,60(4): 1333-1346.
119.Buckly S, Bui KC, Hussain I. Dynamics of FGF-d 3 pepticle activity during rat alveolar epithelial cell proliferative recovery from acute hyperoxia. Am J Physiol, 1996,271(1pt1):L54-60
120.Reynolds SD, Mango GW, Gelein R, et al. Normal function and lack of fibronectin accumulation in kidneys of Clara cell secretory proteinuteroglobin deficient mice. Am J Kidney Dis, 1999,33:541-551.
121.Ramsay PL, Plrdboeu FB, Gameach EM, et al. Dexamet hasone enhances P2 selectin mRNA expression in hyperoxic rat lungs. Inflamm Res, 2000,49:655-665.
122.常立文. 新生儿慢性肺部疾病的诊治及预防. 中国实用儿科杂志, 2003,18(11):641-643
123.里健, 薛辛东. 高氧暴露下早产大鼠血清皮质醇变化的动态研究. 新生儿科杂志, 2005,3(20):111-114.
124.Weinberger B, Laskin DL, Heek DE, et al. Oxygen toxicity in premature infants. toxicol Appl Pharmacol, 2002,181(1):60-67.
125.徐焱, 王丹华. 早产儿慢性肺疾病的炎症反应机制及抗炎治疗. 新生儿科杂志, 2005,20(4):181-184.
126.龚倩, 刘翱, 等. Clara细胞分泌蛋白与哮喘. 国外医学呼吸系统分册, 2005,25(3):226-227.
127. Davis JM. Role of oxidant injury in the pathogensis of neonatal ling disease. Acta Peadiatr, 2002,437(Suppl):23-25.
2. Singh G, Katyal SL, Clara Cell Proteins.Annals of the New York Academy of Sciences, 2000,923:43-58.
3. Singh G, Katyal SL. Clara cells and Clara cell 10 kD protein (CC10). Am J Respir Cell Mot Biol 1997,17:141-143.
4. Chowd hury B, Mantile-Selvaegi G, Kundu GC, et al. Amino acid residues in alpha-helix-3 of human uteroglobin are critical for its phospholipase A2 inhibitory activity. Ann N Y Acad Sci 2000,923:307-311.
5. Thomas NS, Holgate ST. Genes for asthma on chromosome 11: Clin Exp Allergy 1998,28.
6. Arsalane K, Broeckaert F, Knoops B, et al. Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopoly saccharide admini stration. Am J Respir Crit Care Med, 2000,161:1624-1630.
7. Jensen SM, Jones JE, Pass H, Steinberg SM, Linnoila RI. Clara cell 10 kDa protein mRNA in normal and atypical regions of human respiratory epithelium. Int J Cancer, 1994,58:629-637.
8. Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med, 1999,159:646-678.
9. Bochskanl R, Thie M, Kirchner C. Progesterone dependent uptake of uteroglobin by rabbit endometrium. Histochemistry, 1984,80:58.
10. Umland TC, Swaminathan S, Singh, warty v, Furey W, rlecher j, et ai Structure of a human Clara cell phospholipid-binding protein-ligand complexat 1.9 A resolution. Nat Struct Biol, 1994,1:538-45.
11. Murakami M, Kudo 1 Phospholipase A2. J Biochem (Tokyo), 2002,131:285.
12. Geerts L, Jorens PG, Willems J, et al. Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med, 2001,29(10)1920-1924.
13. Lesur O, Bernard A, Arsalane K, et al. Clara cell protein (CC16) induces a phospholipase A2-mediated inhibition of fibrobla-stmigration in vitro [J]. Am J Respir Crit Care Med, 1995,152:290.
14. Geerts L, Jorens PG, Willems J, et al. Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med, 2001:29(10):1920-1924.
15. Rossini GP, Fayard JM, Tessier C, Laugier C. Binding and internization of extracellular type-I phospholipase A2 in uterine stromal cells. Biochem J 1996,315(Pt3):1007-1014.
16. Zhang Z, Kundu GC, Yuan CJ, Ward JM, Lee EJ, DeMayo F, et al. Severefibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science, 1997,276:1408-1412.
17. SpeerC P. New insights in to the pathogenesis of pulmonary inflammation in pre term infants. Biology of the Neonate, 2001,79(3-4):205-209.
18. Lundstrom KE, S haw NJ, T homsonM A.C hronicl ungd isease-cracking the cond ition in the 2 1st century. Biology of the Neonate, 2000,78(2):233-268.
19. Eber E, Zach MS. long term seguelase of bronchopulmonary dysplasia (chronic lung disease of fancy). Thorax, 2001,56:317-323.
20. Lee WL, Downey GP. Neutrophil activation and acute lung injury Currency Opinion in Critical, 2001,7:1-7.
21. 巢建新, 庄得义, 等. 支气管肺发育不良的研究进展. 国外医学儿科学分册. 2005,32(7):207-210.
22. Baier RJ, Loggins J, Kruger TE. Increased interleukin-8 and monocyte chemoattractant protein-1 concentrations in mechanicaly ventilated preter infants with pulmonary hemorrhage. Pediatr Pulmonol, 2002,34(2):131-137.
23. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res, 1999,6(6):641-664.
24. Vyas JR, Kotecha S. The effects of antenatal and postnatal corticosteroids on the preterm lung. Arch DisChild Fetal Neonatal, 1997,77:F147-150.
25. 张向锋, Hussein D.Foda. 高氧所致急性肺损伤大鼠肺组织细胞凋亡的影响. 中华结核和呼吸杂志, 2004,27(7):465-467.
26. 袁莉 . 高氧性肺损伤的研究进展 . 国外医学麻醉学与复苏分册 , 2003,23(3):1001-1005.
27. Gavino R, Johnson L, Bhandari V, et al. Release of cytokines and apoptosis in fetal rat type 2 pneumocytes exposed to hyperoxia and nitric oxide: modulatory efect of dexamethasone and pentoxi line. Cytokine, 2002,21:247-255.
28. Mantel LL, Lee PJ. Singnal transduction pathways in hyperoxia-induced lung cel death. OL Genet Metab, 2000,71:359-370.
29. Cain K, Bratton SB, Langlais C, et al. Apdf -1 oligomerizes into biologically Active approximately 700-kDa and inactive approximately 1, 4-MDa apoptocomplexes. J Biol Chem, 2000,275:6067-6070.
30. Auten RL, Ekekezie II. Blocking leukocyte influx and function to prevent chronic lung disease of prematurity. Pediatr Pulmonol, 2003,35:335-341.
31. 朱晓东, 林庚金. 凋亡通路及其调控研究进展. 国外医学生理.病理科学 及临床分册, 2002,22:248-250.
32. Nanxin L. Is NF-kB the sensor of oxidative stress? Faseb Journal, 1999,13:1137-1143.
33. Li Y, Zhang W, Mantel LL, et a1. Nuclear factor-kappaB is activated by hypemxia but does not protect from cell death. J Biol Chem, 1997,272:20646-20649.
34. Jan ssen YM, Van Houten B, Born PJ, et a1. Cel and tissue responses to oxidative damage. Lab Invest, 1993,69:261-274.
35. Reynolds SD, Mango GW, Gelein R, et al. Normal function and lack of fibronectin accumulation in kidneys of Clara cell secretory protein auteroglobin deficient mice. Am J Kidney Dis, 1999,33:541-551.
36. Broeckaert F, Bernard A. Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy, 2000,30(4):469-475.
37. Hermans C, Knoops B, Wiedig M, et al. Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J, 1999,13(5):1014-1021.
38. Ramsay PL ,DeMayo FJ, Hegemier SE, et al. Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001, 164: (1)155-161.
39. Pilon AL. Rationale for the development of recombinant human CC10 as a therapeutic for inflammatory and fibrotic disease. Ann N Y Acad Sci, 2000,923:280-299.
40. Chandra S, Davis JM, Drexler S, et al. Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury. Pediatr Res, 2003,54:509-515.
41. 王颖. 支气管肺发育不良 (新生儿慢性肺疾病) 的诊断与治疗. 实用医学杂志, 2005,21(17):1859-1860.
42. Saugstad OD. Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD? Acta Paediatr, 1997,86(12):1277-1282
43. Korhonen P, Tammela O, Koivisto AM, et al. Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants. Early Hum Dev, 1999,54(3):245-258.
44. Veness KA, Bottone FG Jr, Stiles AD. Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed new born rats. Pediatr Res, 2000,48(4):434-444.
45. Gaddipati JP, Mani H, Banaudha KK, et al. Picroliv modulates the expression of insulin-like growth factor (IGF)-I, IGF-II and IGF-I receptor during hypoxia in rats. Cell Mot Life Sci, 1999,56(3-4):348-355.
46. Stick S. Pediatric origins of adult lung disease. In the contribution of airway development to paceiatric and adult lung desease. Thorax, 2000,55(7):587-594.
47. Morrow SA, Stahl J. Apoptosis in neonatal murine lung exposed to hyperoxia. Am J Respir Cell Mol Biol, 2001,25(2):150-155.
48. Veness KA, Bottone FG, Stiles AD. Effects of fetinoic acid on airspace development and lung collagen in hyperoxia-exposed newbom rats. Pediatr Res, 2000,48(4):434-444.
49. 钱莉玲, 常立文, 容志惠, 等. 维甲酸治疗新生大鼠高氧肺发育受抑对肺组织基质蛋白酶及其组织抑制剂表达的影响. 实用儿科临床杂志, 2002,17(6):602-604.
50. Cherif A, Marrakchi Z, Chaouachi S, et al. Broncho pulmonary dysplasia and corticosteroid therapy. Arch Pediatr, 2002,9:159-168.
51. 万秋红. TGF-β超家族信号传递机制研究进展. 国外医学分子生物学分册, 2000,22(3):137-142.
52. Buckley S, Barsky L, Driscoll B, et al. Apoptosis and DNA damage in type 2 alveolar epithelial cells cultured from hyperoxic rats. Am J Physiol, 1998,274(5Pt1):L714-L720.
53. 袁安波, 石晓峰, 上官明, 等. 新生儿急性肾功能衰竭时血、尿胰岛素样生长因子-I 的变化及意义. 中华儿科杂志, 2003,21(5):306-308.
54. 贲晓明. 胰岛素样生长因子与机体营养代谢和免疫功能. 国外医学儿科学分册. 2000,27:57-59.
55. 白波, 陈波. IGF s 在 IUGR 儿生后追赶生长中的作用. 国外医学妇幼保健分册, 1999,10:112-124.
56. 白波. 胰岛素样生长因子与胎儿生长发育. 国外医学儿科学分册. 2000,27:4-6.
57. 陈 娟 . 胰 岛 素 样 生 长 因 子 与 生 长 发 育 . 中 华 围 产 医 学 杂 志 . 1999,2:126-128.
58. Bimbacher R, Amann G,Breitschopf H, et al. Cellular localization of insulin-like growth factor II mRNA in the human fetus and the placenta: detection with a digoxigenin-labeled cRNA probe and immunocytochemistry. Pediatr Res, 1998,43(5):614-620.
59. Moreno B, Rodriguez-Manzaneque JC, Perez-Castillo A, et al. Thyroid hormone controls the expression of insulin--like growth factor I recptor gene at different levels in lung and heart of developing and adult rats. Endocrinology, 1997,138: 1194-1203.
60. Lee CI, Goldstein O, Han VK, et al. IGF-II and IGF binding protein (IGFBP-1, IGFBP-3) gene expression in fetal rhesus monkey tissues during the second and third trimesters. Pediatr Res,. 2001,49(3):379-87.
61. Vande Wetering JK, Elfring RH, Oosterlaken MA, et al. Perinatal expression of IGFBPs in rat lung and its hormonal regulation in fetal lung explants. Am J Physiol, 1997,273(6Pt1):L1174-1178.
62. Kumar VH, Ryan RM.Growth factors in the fetal and neonatal lung. Front Biosci, 2004,1(9):464-80.
63. Tarantal AF, Hunter MK, Gargosky SE. Direct distribution of insulin-like growth binding protein mRNAs and peptides during rat lung deveopment. Endocrinology, 1997,155:313.
64. Wallen LD, Han VK. Spactial and temporal distribution of insulin-like grow th factors I and II during development of rat lung, Am J Physiol, 1994,267:L531-542.
65. Besnard V, Corroyer S, Trugnan G, et al. Distinct paterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells. Biochim Biophys Acta, 2001,1538(1):47-58.Griffin M,
66. 刘汉楚, 常立文, 容志惠, 等. 胰岛素样生长因子与新生大鼠高氧性肺损伤的关系. 中华儿科杂志, 2004,7:532-533.
67. Bhandari R, Hamilton G, et al. Alveolar type II cell fibroblast interactions, synthesis and secretion of surfactant and type I collagen. J Cell Sci, 1993,105(pt2):423-432.
68. Noguchi A, Nelson T. IGF-I stimulates tropoclastin synthesis in neonatal rat pulmonary fibroblasts. Pediatr Res, 1991,30:248-251.
69. Chadelat K, Boule M, Corroyer S, et al. Expression of insulin-like growth factors and their binding proteins by bronchoalveolar cells from children with and without interstitial lung disease. Eur Respir J, 1998,11(6):1329-1336.
70. Cazals V, M uhieddinc B, Maitre B, et al. Insulin-like growth factor, their binding proteins, and transforming growth factor bctal in oxidant-arrested lung alveolar epithelial cells J Biol Chem, 1994,269:14111-14117.
71. 龚小慧, 孙波. 急性肺损伤时肺表面活性物质的变化及意义. 国外医学儿科学分册. 2005,32(1):34-36.
72. Krein PM, Sabatini PJ, Tinmouth W, et al. Localization of insulin-like growth factor-I in lung tissues of patients with fibroproliferative acute respiratory distress syndrome. Am J Respir Crit Care Med. 2003,167(1):83-90.
73. Chaillry HB, Rubio S, Rougier JP, et al. Expression hydrophilic surfactant protein by mesentery cell in rat and man. Biochem J, 1997,328(Pt1):251-256.
74. 陶少华. 人肺表面活性物质结合蛋白 A 的研究现状. 国外医学妇幼保健分册, 1997,8:117.
75. Levine AM, Whitsett JA.Pulmonary collectins and innate dedense of the lung. Microbers infect, 2001,3(2):161-166.
76. Hickman-Davis JM, Fang FC, Nathan C, et al. Lung surfactant and reactive oxygen nitrogen species: antimicrobial activity and host pathogen interactions. Am J Physiol Lung Cell Mol Physiol, 2001,281(3):L517-523.
77. Mccormack FX, Whitsett JA. The pulmonary collection SP-A and SP-D, orchestrate innate immunity in the lung. J Clin logest, 2002,109(6):707-712.
78. Wu YZ, Medjane S, Chabot S, et al. Surfatant protein-A and phosphatidylglycerol suppress type Ⅱ A phospholipase A2 synthesis vianuclear factor kappab. Am J Respir Crit Care Med, 2003,168(6):692-699.
79. Quintero OA, KorThagen TR, Wright JR.Surfactant protein A regulates surfactant phospholipid clessnce after LPS-induced injury in vivo. Am J Physiol Lung Cell Mol Phydiol, 2002,283(1):76-85.
80. Schyjze O, Wesse J. Oxygen radical sassecond messen ger sofgen of gene expression. Dtsch Med Wochenschr, 1996,121:1301-1302.
81. Jobe AH, Ikegami M. Surfactant and acute 1ung injury. Proc Assoc Am Physicians, 1998,110(6):489-495.
82. Hasting RH, Monitoring alveolar epithelial function in acute lung injury. J Clin Monit Comput, 2000,16(5)385-392.
83. Cheng IW, Ware LB, Greene KE, et al. Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med, 2003,31(1):20-27.
84. Bersten AD, Hunt T, Nicholas TE, et al. Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute resp iratory failure. Am J Respir Crit Care Med, 2001,164:648
85. Attalah HL, Wu Y, Alaoui AM, et al. Induction of type-ⅡA secretory phospholipase A2 in animal models of acute lung injury. Eur Respir J, 2003,21(6):1040-1045.
86. Chabot S, Koumanov K, Lambeau G, et al. Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2. J Immunol, 2003,171(2):995-1000.
87. Mallampalli RK, Ryan AJ, Salome RG, et al. Tumor necrosis factor-alpha inhibits expression of CTP: phosphocholine cytidylyltransferase. J Biol Chem, 2000,275(13):9699-9708.
88. Creuwels LAJM, van Golde LMG, Haagsman HP. The pulmonary surfactant system. biochemical and clinical aspects Lung, 1997,175:1-39.
89. Holm BA, Enhorning G, Notter RH.Abiophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids, 2002,49:49-55.
90. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol, 2003,8(1):73-81.
91. Vancher YE. Bronchopulmonary dysplasia: an enduring chalenge. Pediatr Rev, 2002,23(3):349-358.
92. Greene KE, Wright JR, Steinberg KP, et al. Serial changes in surfactant associated proteins in lung serum beform and after onsed of ARDS. Am J Respir Crit Care Med, 1999,160(6):1843-1850.
93. Moya FD, Montes HF, ThomasuL, et al. Surfactant protein-A and saturated phatidyl cholinein respiratory distress syndrome. Am J Respir Crit Care Med, 1999,150:1672-1677.
94. Crdoso WV, Mitsialis SA, Brody JS, et al. Retinoic acid alters the expression of pattern-related genes in the developing rat lung. Dev Dyn, 1996,207(1):47-59.
95. Fu ZW, NoguchiT, Kato H. Vitamin A deficiency reduces insulin-like growth factor (IGF)-I gene expression and increases IGF-I receptor and insulin receptor gene expression in tissues of Japanese quail .J Nutr, 2001,131(4):1189-1194.
96. sbeyrat E, Besnard V, Corroyer S, et al. Retinoic acid-induced proliferation of lung alveolar epithelial cells: relation with the IGF system, Am J Physiol, 1998,275(1pt1):L71-79.
97. Halliday HL. The effect of postnatal steroids on growth and development. J Perinat Med, 2001,29(4):281-285.
98. Massaro GD, Massaro D. Postnatal treatment with retinoic acid incrases the number of pulmonary alveoli in rats. Am J Physiol. 1996,270(2Ptl):L305-310.
99. Vande JK, Elfring RH, Oosterlaken MA, et al. Perinatal expression of IGFBPs in rat lung and its hormonal regulation in fetal lung explants. Am J Physiol, 1997,273(6 Pt1):L1174.
100.Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol, 2000,279(3):L600-607.
101.Lensmar C, Nord M, Gudmundsson GH, et al. Decreased pulmonary levels of the anti-inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics. Cell Mol Life Sci, 2000,57:976-981.
102.迟春花, 何冰, 汤秀英, 等. 烟草雾吸入导致慢阻肺机制的实验研究-大鼠 Clara 细 胞 结 构 及 其 分 泌 蛋 白 的 变 化 . 心 肺 血 管 病 杂 志 , 2000,19(3):224-227.
103.汪隽瑛, 等. 哮喘大鼠肺表面活性物质结合蛋白 A 的变化及其意义. 第二军医大学学报, 2004,25(11):1255-1257.
104.Hayashi T, Stekler-Stevenson WG, Fleming MV, et al. Immunohistochemical study of metalloprpteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol, 1996,149(4):1241-1256.
105.Muler W, Pichler G. Results of mechanical ventilation in premature infants with respiratory distress syndrome. Wien Med Wochenschr, 2002,152(12):5-8.
106.Jobe AH. Lung development and lung injury-the new BPD. 中国当代儿科杂志, 2001,3(4):433-437.
107.富建华, 薛辛东. 转化生长因子-β与早产儿慢性肺疾病. 中华儿科杂志, 2003,41:313-315.
108.Jobe AH. Lung development and maturation. In: Fanarof AA, Martin RJ. eds. Neonatal-Prenatal Medicine: Diseases of the fetus and infant. Philadelphia. Elsevier Science, 2002,973.
109.Speer CP. Newin sights in to the pathogenesis of pulmonary inflammation in preterm infants. Biology of the Neonate, 2001,79(3-4):205-209.
110.VyasJR, KotechaS. The effects of an tenatal and postnatal corticosteroids on the preterm lung. Arch Dischild Fetal Neonatal, 1997,77:F147-150.
111.Editorial. preand postnatal lung development, maturation, and plasticity. Am J Physiol Lung Cell Mol Physiol, 2002,282:L341-L344.
112.Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res, 1999,6(6):641-643.
113.Bilodeau JF, Faure R, Piedboeuf B, et al. Hyperoxia induces S-phase cell-cycle arrest and p21 (Cipl/Wafl)-independent Cdk2 inhibition in humacarcinoma T47D-H3 cells. Exp Cell Res, 2000,256(2):347-357.
114.富建华, 薛辛东. 细胞因子在早产儿慢性肺疾病发生中作用, 中国当代儿科杂志, 2003,5:488-490.
115.Qin LL, Chang LW, Zhang QS, et al. Lung injury of preterm rats induced by prolonged exposour to high oxygen concentration of 85%. Chin J Contemp Pediatr, 2003,(2)95-99.
116.Moss TJ, Newnham JP, Wilett KE, et al. Early gestational intra-amniotic endotoxin. lung function, surfactant, and morphometry. Am J Respir Crit Care Med, 2002, 15:165(6):805-811.
117.Jobe AH, Ikegami M. Prevention of bronchopulmonary dysplasia. CurrOpin Pediatr, 2001,3(2):124-129
118.Coalson JJ, Winter VT, Siler-Khodr T, et al. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med, 1999,60(4): 1333-1346.
119.Buckly S, Bui KC, Hussain I. Dynamics of FGF-d 3 pepticle activity during rat alveolar epithelial cell proliferative recovery from acute hyperoxia. Am J Physiol, 1996,271(1pt1):L54-60
120.Reynolds SD, Mango GW, Gelein R, et al. Normal function and lack of fibronectin accumulation in kidneys of Clara cell secretory proteinuteroglobin deficient mice. Am J Kidney Dis, 1999,33:541-551.
121.Ramsay PL, Plrdboeu FB, Gameach EM, et al. Dexamet hasone enhances P2 selectin mRNA expression in hyperoxic rat lungs. Inflamm Res, 2000,49:655-665.
122.常立文. 新生儿慢性肺部疾病的诊治及预防. 中国实用儿科杂志, 2003,18(11):641-643
123.里健, 薛辛东. 高氧暴露下早产大鼠血清皮质醇变化的动态研究. 新生儿科杂志, 2005,3(20):111-114.
124.Weinberger B, Laskin DL, Heek DE, et al. Oxygen toxicity in premature infants. toxicol Appl Pharmacol, 2002,181(1):60-67.
125.徐焱, 王丹华. 早产儿慢性肺疾病的炎症反应机制及抗炎治疗. 新生儿科杂志, 2005,20(4):181-184.
126.龚倩, 刘翱, 等. Clara细胞分泌蛋白与哮喘. 国外医学呼吸系统分册, 2005,25(3):226-227.
127. Davis JM. Role of oxidant injury in the pathogensis of neonatal ling disease. Acta Peadiatr, 2002,437(Suppl):23-25.